Intake of selective beta blockers has no impact on survival in patients with epithelial ovarian cancer. [electronic resource]
Producer: 20170530Description: 181-186 p. digitalISSN:- 1095-6859
- Adrenergic beta-Antagonists -- therapeutic use
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bevacizumab -- administration & dosage
- Carboplatin -- administration & dosage
- Carcinoma, Ovarian Epithelial
- Disease-Free Survival
- Female
- Germany -- epidemiology
- Humans
- Middle Aged
- Neoplasms, Glandular and Epithelial -- mortality
- Ovarian Neoplasms -- mortality
- Paclitaxel -- administration & dosage
- Postoperative Complications -- epidemiology
- Retrospective Studies
- Severity of Illness Index
- Survival Rate
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.